Avricore Health (AVCRF) Other financing activities (2014 - 2021)
Avricore Health (AVCRF) reported Other financing activities of -$718.76 for Q4 2021, up 96.11% year-over-year from -$366.52 in Q4 2020, and up 99.07% quarter-over-quarter from -$77184.8 in Q1 2021.
Avricore Health (AVCRF) Other financing activities (2014 - 2021) Analysis & Trends
Avricore Health (AVCRF) has 3 years of Other financing activities data on file, last reported at -$718.76 in Q4 2021.
- Other financing activities for Q4 2021 came in at -$718.76, up 96.11% year-over-year; the trailing twelve-month figure through Dec 2021 was -$77903.5 (changed N/A YoY), and the FY2021 annual result was -$78675.2, down 317.54% from the prior year.
- Other financing activities climbed to -$718.76 in Q4 2021 per AVCRF's latest filing, from -$77184.8 in the prior quarter.
- Over five years, Other financing activities peaked at -$718.76 in Q4 2021 and troughed at -$77184.8 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Avricore Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -718.76 |
| Dec 31, 2021 | -718.76 |
| Mar 31, 2021 | -77,184.78 |
| Mar 31, 2021 | -77,184.78 |
| Dec 31, 2020 | -18,453.80 |
| Dec 31, 2020 | -18,453.80 |
| Dec 31, 2014 | 922,690.60 |
| Dec 31, 2014 | 922,690.60 |
| Mar 31, 2014 | 181,137.83 |
| Mar 31, 2014 | 181,137.83 |